The future of clinical research
Clinical research is the most expensive and often most time-consuming phase of drug development. This fact puts huge commercial pressures on businesses and, in...
Bringing in change with Brexit
With a post-Brexit deal agreed, it is time to weigh up the opportunities and the risks for industry. From clinical trials to marketing authorisation,...
The cost of COVID-19 on lung cancer progress
Lung cancer is the largest cause of cancer deaths in the world and there is no doubt that the COVID-19 pandemic has had a...
How the NHS and pharma are working together to improve cancer services
Despite a difficult year for cancer services, cancer survival rates are improving in the UK, and it is vital that all parts of the...
The importance of adherence
What makes the difference between a patient with a chronic condition adhering or not adhering to treatment? Poor adherence to treatment of chronic disease has...
How National Patient Recruitment Centres will aid clinical research
New National Patient Recruitment Centres (NPRCs) are set to provide opportunities for local patients to be involved with invaluable clinical research studies and trials....
NHS Reset report – diving into the detail
COVID-19 has exacerbated many of the health and care services’ pre-existing challenges. But it has also shown what teams can achieve when they have...
AF Toolkit to tackle avoidable strokes
With approximately 15,000 people a year being admitted to hospital following an atrial fibrillation (AF) related stroke, the AHSN Network launched the AF Toolkit...
Is your sales force effective, post-pandemic?
Kevin Lennon, Business Unit Director, Star OUTiCO, has over 17 years of industry experience, with a demonstrated history of leading teams to effectively operate...
Guide to pharma e-detailing
Mehrnaz Campbell, Founding Director of Cheemia and Lindsey Brookes, an E-Detailing Consultant for Cheemia look how the COVID-19 pandemic has moved a large proportion...
Latest articles
Career close-up: Alessandra Dorigo
Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...
JCVI advises all UK 16- and 17-year-olds should be offered COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice that all 16 to 17-year-olds should be offered a first dose of the...
OPEN Health acquires medical communications agency Spirit
OPEN Health has announced the acquisition of North West UK-based medical communications agency Spirit. A statement from OPEN Health stated that integrating the Spirit business...
Popular articles
MHRA approves first immunotherapy treatment for mesothelioma
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the combination of nivolumab plus ipilimumab for the first-line treatment of adult patients with...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Challenges in recruiting during the pandemic
Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
Syneos Health and Aetion partner to offer real-world evidence solutions
Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. The partnership...
Career close-up: Alessandra Dorigo
Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...